Limitations and use of the Morpheus-V5 dual reporter virus in assessing interventions that target HIV latency
Kiho Tanaka(The University of Melbourne), Sharon R. Lewin(Peter Doherty Institute), Jesslyn Ong(The University of Melbourne), Michael J. Roche(West Chester University), Ajantha Rhodes(The University of Melbourne), Hannah A. D. King(Henry M. Jackson Foundation), Youry Kim(The University of Melbourne), Carolin Tumpach(Peter Doherty Institute), Anna C. Hearps(Burnet Institute)
Cited by 1
Related Papers
Immune checkpoint blockade in infectious diseases
|Nature reviews. Immunology|2017|571
Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
|PLoS Pathogens|2014|509
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
|Nature Medicine|2021|367
A Functional Role for Aβ in Metal Homeostasis? N‐Truncation and High‐Affinity Copper Binding
|Angewandte Chemie International Edition|2015|128
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy
|Science Translational Medicine|2022|101